STAT3 and lung adenocarcinoma: In the second cohort, we performed IHC analysis of CD47 and p-STAT3 expression in an in-house–generated tissue microarray containing paired tumor samples and adjacent normal tissue samples from 12 patients with KRASMUT lung adenocarcinoma and 28 patients with KRASWT lung adenocarcinoma.